A case of recurrent cervical cancer with cortical blindness after chemotherapy with cis-platinum

Acta Obstetrica et Gynaecologica Japonica

Volumn 49, Issue 3, 1997, Pages 195-198

  Muramatsu, Toshinari ^a   Shinozuka, Takao ^a   Hirasawa, Takeshi ^a   Maeda, Hironobu ^a   Miyamoto, Tsuyoshi ^a   Kuroshima, Yoshiof ^a   Makino, Tsunehisa ^a   Tanaka, Yutaka ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Cisplatin; Cortical blindness

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CEREBRAL BLINDNESS; CLINICAL FEATURE; FEMALE; HUMAN; RECURRENT DISEASE; UTERINE CERVIX CANCER;

EID: 0030951720     PISSN: 03009165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Berman IJ, Mann MP. Seizures and transient cortical blindness associated with cisplatinum(II) diamminedichloride (PDD) therapy in a thirty-year-old man. Cancer 1980 ; 45 : 764-766
2. Pippitt CH Jr, Muss HB, Homesley HD, Jobson VW. Cisplatin-associated cortical blindness. Gynecol Oncol 1981 ; 12 : 253-255
3. Cattanco MT, Filipazzi V, Piazza E, Damiani E, Mancarella G. Transient blindness and seizure associated with cisplatin therapy. J Cancer Res Clin Oncol 1988 ; 114 : 528-530
4. Gorman DJ, Kefford R, Stuart-Harris R. Focal encephalopathy after cisplatin therapy. Med J Aust 1989 ; 150 : 399-401
5. Highley M, Meller ST, Pinkerton CR. Seizures and cortical dysfunction following high-dose cisplatin administration in children. Med Pediat Oncol 1992 ; 20 : 143-148
6. Mead GM, Arnold AM, Green JA, Macbeth FR, Williams CJ, Whitehouse JM. Epileptic seizures associated with cisplatin administration. Cancer Treat Rep 1982 ; 66 : 1719-1722
7. Lindeman G, Kefford R, Stuart Harris R. Cisplatin neurotoxicity. N Engl J Med 1990 ; 323 : 64-65
8. Briick W, Heise E, Friede RL. Leukoence-phalopathy after cisplatin therapy. Clin Neuropathol 1989 ; 8 : 263-265
9. Synder RD, Seelinger DF. Methylmercury poisoning. Clinical follow-up and sensory nerve conduction studies. J Neurol Neurosurg Psychiat 1976 ; 39 : 701-704
10. O'Brien MER, Tonge K, Blake P, Moskoric E, Willshaw E. Blindness associated with high-dose carboplatin. Lancet 1992 ; 339 : 558
11. Rankin EM, Pitts JF. Ophthalmic toxicity during carboplatin therapy. Ann Oncol 1993 ; 4 : 337-338
12. Diamond SB, Rudolph SH, Lubicz SS, Deppe G, Cohen CJ. Cerebral blidness in association with cis-platinum chemotherapy for advanced carcinoma of the fallopian tube. Obstet Gynecol 1982 ; 59 : 84s-86s
13. Cohen RJ, Cuneo RA, Cruciger MP, Jackman AE. Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin. J Clin Oncol 1983 ; 1 : 392-393
14. Crispino S, Pizzocaro G, Solero CL, Rodari A, Monfardini S. Transient left homonymous hemianopsia during treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin. Chemioterapia 1984 ; 3 : 337-339
15. Hitchins RN, Thomson DB. Encephalopathy following cisplatin, bleomycin and vinblastine therapy for non-seminomatous germ cell tumor of testis. Aust NZ J Med 1988 ; 18 : 67-68
16. Philip PA, Carmichael J. Harris AL. Convulsions and transient cortical blindness after cisplatin. Br Med J 1991 ; 302 : 416
17. Young DC, Mitchell A, Kessler J, Christman JE. Cortical blindness and seizures possibly related to cisplatin, vinblastine, and bleomycin treatment of ovarian dysgerminoma. J Am Osteopath Assoc 1993 ; 93 : 502-507